Orthopedic Bone Cement Market Size, Share, Growth, and Industry Analysis, By Type (Antibiotic-Loaded Bone Cement, Non-Antibiotic Bone Cement), By Application (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others), Regional Insights and Forecast to 2034

Orthopedic Bone Cement Market Overview

The Orthopedic Bone Cement - Market size was valued at USD 736.87 million in 2025 and is expected to reach USD 1062.68 million by 2034, growing at a CAGR of 3.8% from 2025 to 2034.

The Orthopedic Bone Cement Market Size is directly associated with more than 2.5 million joint replacement procedures performed globally each year, including over 1.4 million hip and 1.1 million knee arthroplasties. Nearly 70% of total hip replacements utilize polymethyl methacrylate (PMMA) bone cement for implant fixation. Over 65% of elderly patients aged above 65 years undergoing arthroplasty require cemented fixation techniques. The Orthopedic Bone Cement Market Growth is influenced by over 180 million osteoporosis cases worldwide, contributing to more than 9 million fractures annually. Approximately 55% of revision surgeries involve antibiotic-loaded bone cement, reinforcing consistent Orthopedic Bone Cement Market Trends.

In the United States, more than 1 million total joint replacement procedures are conducted annually, including approximately 790,000 knee replacements and 544,000 hip replacements. Around 72% of primary hip arthroplasties use cemented or hybrid fixation methods. The U.S. population aged 65 years and older exceeds 58 million, representing nearly 17% of the total population, driving procedural volume growth. Nearly 300,000 vertebroplasty and kyphoplasty procedures are performed annually, requiring bone cement in 100% of cases. The Orthopedic Bone Cement Market Share in the USA benefits from over 6,100 hospitals and 11,000 ambulatory surgical centers performing orthopedic surgeries regularly.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:70%, 65%, 72%, 58%, 55%, 60%, 48%, 62%, 75%, 68%
• Major Market Restraint:18%, 22%, 27%, 31%, 24%, 19%, 29%, 26%, 21%, 34%
• Emerging Trends: 44%, 53%, 61%, 47%, 39%, 58%, 66%, 42%, 36%, 49%
• Regional Leadership:38%, 30%, 21%, 7%, 4%, 35%, 28%, 23%, 9%, 5%
• Competitive Landscape:24%, 19%, 15%, 12%, 8%, 6%, 5%, 4%, 3%, 2%
• Market Segmentation:57%, 43%, 64%, 21%, 9%, 6%, 68%, 32%, 59%, 41%
• Recent Development:41%, 37%, 52%, 46%, 33%, 48%, 29%, 55%, 44%, 38%

Orthopedic Bone Cement Market Latest Trends

The Orthopedic Bone Cement Market Trends highlight that antibiotic-loaded bone cement accounts for nearly 57% of total product usage in revision arthroplasty procedures. Around 66% of orthopedic surgeons prefer premixed cement formulations to reduce preparation time by 25%. Vacuum mixing systems are used in 62% of operating rooms to minimize porosity by nearly 40%, enhancing implant fixation strength. Over 53% of knee replacement surgeries worldwide involve cemented fixation techniques.

The Orthopedic Bone Cement Market Insights indicate that high-viscosity cement formulations represent approximately 48% of procedures due to improved handling characteristics within 5 to 8 minutes of working time. Radiopaque agents such as barium sulfate are incorporated in 100% of commercially available bone cement to ensure intraoperative imaging visibility. More than 9 million fragility fractures annually contribute to rising vertebral augmentation procedures, with cement usage in 100% of kyphoplasty cases. The Orthopedic Bone Cement Market Outlook reflects increasing demand in emerging markets where orthopedic procedure volumes have increased by 28% between 2020 and 2024.

Orthopedic Bone Cement Market Dynamics

DRIVER

Rising volume of joint replacement and fracture repair surgeries

Globally, more than 2.5 million joint replacement procedures are performed annually, with projections exceeding 4 million procedures within 10 years. Around 70% of hip arthroplasties rely on cemented fixation, especially in patients aged above 65 years. Osteoarthritis affects nearly 528 million individuals worldwide, contributing to increased arthroplasty rates. Approximately 9 million osteoporotic fractures occur each year, and 20% of hip fracture patients require cemented implants. In the USA alone, knee replacement procedures are projected to surpass 1.2 million annually by 2030. These figures strongly support Orthopedic Bone Cement Market Growth and sustained Orthopedic Bone Cement Market Forecast expansion.

RESTRAINT

Risk of bone cement implantation syndrome and regulatory scrutiny

Bone cement implantation syndrome occurs in approximately 1% to 5% of cemented arthroplasty procedures, with severe complications in nearly 0.1% of cases. Around 22% of surgeons report concerns regarding cardiopulmonary complications during cement pressurization. Regulatory compliance requirements increased by 30% between 2021 and 2024 for Class II and Class III orthopedic materials. Nearly 27% of hospitals have implemented stricter monitoring protocols during cemented procedures. Product recalls related to sterilization or mixing inconsistencies impacted approximately 3% of distributed batches between 2020 and 2023, affecting Orthopedic Bone Cement Industry Analysis.

OPPORTUNITY

Growing geriatric population and emerging market penetration

The global population aged 65 years and older is expected to reach 1.6 billion by 2050, compared to 771 million in 2022. Around 60% of joint replacement candidates fall within the 65+ age group. In Asia-Pacific, orthopedic procedure volumes increased by 28% over 4 years. Nearly 40% of hospitals in emerging economies upgraded orthopedic surgical infrastructure between 2019 and 2024. The Orthopedic Bone Cement Market Opportunities are supported by increasing healthcare expenditure allocation toward orthopedic implants, representing approximately 15% of total hospital surgical procurement budgets in developed nations.

CHALLENGE

Availability of cementless fixation alternatives

Cementless implants are used in nearly 45% of primary hip replacements in patients younger than 60 years. Around 35% of orthopedic surgeons prefer hybrid fixation techniques. Technological advancements improved porous implant surfaces by 25%, enhancing biological fixation. Approximately 31% of total knee arthroplasties in developed markets are performed without cement. These shifts influence Orthopedic Bone Cement Market Share distribution and create competitive pressure within the Orthopedic Bone Cement Market Research Report landscape.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The Orthopedic Bone Cement Market is segmented by type and application. Antibiotic-loaded bone cement accounts for 57% of total usage, while non-antibiotic bone cement represents 43%. By application, hospitals dominate with 64% share, followed by ambulatory surgical centers at 21%, specialty clinics at 9%, and others at 6%. The Orthopedic Bone Cement Market Analysis indicates increasing demand for infection prevention strategies and optimized fixation techniques across all healthcare settings.

By Type

Antibiotic-Loaded Bone Cement:Antibiotic-loaded bone cement constitutes 57% of the Orthopedic Bone Cement Market Size. Gentamicin-loaded formulations represent nearly 65% of antibiotic variants used globally. Around 55% of revision surgeries utilize antibiotic-loaded cement to reduce infection risk by approximately 40%. Infection rates following joint replacement range between 1% and 2%, and antibiotic cement reduces reinfection incidence by nearly 30%. More than 500,000 revision procedures annually involve antibiotic cement application, supporting Orthopedic Bone Cement Market Growth.

Non-Antibiotic Bone Cement:Non-antibiotic bone cement accounts for 43% of total procedures, primarily used in primary arthroplasty cases with low infection risk. Approximately 70% of primary knee replacements rely on standard PMMA cement without antibiotics. Working times range between 5 and 10 minutes, depending on viscosity grade. Over 1.5 million primary joint procedures annually utilize non-antibiotic cement formulations, ensuring consistent Orthopedic Bone Cement Market Share stability.

By Application

Hospitals:Hospitals represent 64% of total Orthopedic Bone Cement Market Share, performing more than 2 million joint procedures annually. Nearly 80% of tertiary hospitals maintain dedicated orthopedic operating rooms equipped with vacuum mixing systems. Infection control protocols are implemented in 100% of accredited facilities.

Ambulatory Surgical Centers (ASCs):ASCs account for 21% of procedures, with over 11,000 centers operating in the USA alone. Around 35% of outpatient knee arthroplasties are performed in ASCs. Procedure volumes in ASCs increased by 18% between 2020 and 2024.

Specialty Clinics:Specialty clinics contribute 9% share, focusing on minimally invasive orthopedic procedures. Approximately 120,000 vertebral augmentation cases annually are conducted in specialty settings.

Others:Other facilities represent 6%, including trauma centers handling nearly 1.6 million fracture surgeries annually, many requiring cement augmentation.

• 

  Download Free sampleto learn more about this report.

 Regional Outlook

• North America holds 38% market share.
• Europe accounts for 30% share.
• Asia-Pacific contributes 21% share.
• Middle East & Africa represent 7% share.

North America

North America dominates with 38% of the Orthopedic Bone Cement Market Size. Over 1 million joint replacements are performed annually in the USA and Canada combined. Approximately 72% of hip arthroplasties involve cemented techniques. The geriatric population exceeds 58 million in the USA. Around 85% of hospitals use vacuum mixing systems. Infection rates are monitored in 100% of accredited surgical centers.

Europe

Europe accounts for 30% share, with over 1.2 million joint replacements annually. Countries such as Germany, the UK, and France collectively perform more than 600,000 procedures each year. Approximately 65% of hip replacements in Europe use cemented fixation. The population aged above 65 years exceeds 100 million across the region.

Asia-Pacific

Asia-Pacific holds 21% share, with over 800,000 joint replacement procedures annually. China and India account for nearly 60% of regional procedures. Orthopedic infrastructure expanded by 28% between 2020 and 2024. Cemented fixation is used in approximately 55% of hip replacements.

Middle East & Africa

Middle East & Africa represent 7% share, with nearly 150,000 joint procedures annually. Around 45% of procedures are conducted in private hospitals. Healthcare infrastructure investment increased orthopedic surgical capacity by 22% over 3 years.

List of Top Orthopedic Bone Cement Companies

• Stryker Corporation
• Zimmer Biomet
• DePuy Synthes
• Smith & Nephew, Inc.
• DJO Global
• Aegis Spine
• Alphatec Spine
• Becton Dickinson
• Cook Medical
• DePuy Synthes
• Elite Surgical
• Evolutis
• Exactech

Top 2 Companies with Highest Market Share:

• Stryker Corporation – 24% market share, portfolio covering over 70% of cemented arthroplasty systems.
• Zimmer Biomet – 19% market share, presence in more than 100 countries with over 1 million cement-related procedures annually.

Investment Analysis and Opportunities

Orthopedic device R&D spending accounts for nearly 12% of total medical device investment budgets globally. Around 48% of manufacturers increased production capacity between 2021 and 2024. Over 35% of new orthopedic implant launches include compatible bone cement systems. Emerging economies allocated approximately 15% of hospital capital expenditure toward orthopedic infrastructure upgrades. More than 500 clinical trials related to orthopedic implants and cement technologies were registered between 2020 and 2024. The Orthopedic Bone Cement Market Opportunities are supported by increasing outpatient procedure volumes, which grew by 18% in 4 years. Digital surgical planning adoption increased by 29%, enhancing cement application precision.

New Product Development

In 2024, approximately 52% of newly introduced bone cement products featured enhanced viscosity control within 6 minutes of mixing. Antibiotic elution duration improved by 25% in advanced formulations. Over 40% of new cement systems incorporated improved radiopacity for enhanced imaging clarity. Biodegradable additives were tested in 12% of experimental product pipelines. Mixing system efficiency improved by 33%, reducing preparation errors by 20%. Pre-measured packaging solutions reduced contamination risk by 18%. Nearly 60% of manufacturers introduced vacuum-sealed delivery systems between 2023 and 2025, strengthening Orthopedic Bone Cement Industry Report innovation benchmarks.

Five Recent Developments (2023–2025)

1. In 2023, a major manufacturer expanded production capacity by 35%, reaching over 3 million cement units annually.
2. In 2024, a company launched antibiotic-loaded cement with 30% extended antibiotic release duration.
3. In 2024, regulatory approval was granted in 20 countries for a high-viscosity cement variant with 15% improved compressive strength.
4. In 2025, a manufacturer partnered with 200 hospitals to standardize vacuum mixing systems.
5. In 2025, a new delivery cartridge system reduced preparation time by 22% in over 50 surgical centers.

Report Coverage of Orthopedic Bone Cement Market

This Orthopedic Bone Cement Market Research Report covers over 25 countries and analyzes 2 major product types and 4 application segments. The Orthopedic Bone Cement Market Analysis evaluates more than 150 quantitative indicators, including over 2.5 million annual joint procedures and 9 million fracture cases worldwide. The study assesses hospital adoption rates exceeding 80% in developed markets and tracks over 200 product approvals between 2020 and 2025. The Orthopedic Bone Cement Market Forecast incorporates 10 years of historical surgical volume data and 5-year procedural projections. The Orthopedic Bone Cement Industry Analysis examines regulatory compliance across 4 major regions and profiles more than 20 manufacturers globally, providing strategic Orthopedic Bone Cement Market Insights for B2B stakeholders.